Discover our comprehensive range of 50+ pharmaceutical peptides and therapeutic compounds, designed to meet the highest quality standards for the pharmaceutical, biotechnology, and healthcare industry.
Professional peptide products to meet your diverse needs
Liraglutide is a GLP-1 receptor agonist that has completed NDC registration. It is a human glucagon-like peptide-1 (GLP-1) analog that lowers blood glucose by increasing insulin secretion, inhibiting glucagon secretion, and delaying gastric emptying. In addition, it can also inhibit the appetite center, reduce food intake, and help with weight management.
Retatrutide is a novel GLP-1/GIP/glucagon receptor triple agonist that has completed NDC registration. It is a peptide drug that regulates blood glucose and body weight by simultaneously activating the three receptors. Clinical studies have shown that it has significant efficacy in the treatment of obesity and related metabolic diseases, and only requires once-weekly injection, resulting in good patient compliance.
Contact our team to discuss custom peptide synthesis and bulk orders for your pharmaceutical and biotechnology needs.
